Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2014-09-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-014-3129-xPMID 25212176PMCID PMC4768870
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dendritic cells and cancer immunotherapy.

  2014cited by this paper
• Next‐generation peptide vaccines for advanced cancer

  2013cited by this paper
• The Nucleocapsid Protein of Rift Valley Fever Virus Is a Potent Human CD8+ T Cell Antigen and Elicits Memory Responses

  2013cited by this paper
• Mammaglobin-A cDNA vaccination of breast cancer patients induces antigen-specific cytotoxic CD4+ICOShi T cells

  2013cited by this paper
• The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer

  2013cited by this paper
• Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen.

  2012cited by this paper
• Design of immunogenic and effective multi-epitope DNA vaccines for melanoma

  2012cited by this paper
• Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers

  2011cited by this paper
• Prediction of epitopes using neural network based methods.

  2011cited by this paper
• Blockade of the B7-H1/PD-1 Pathway for Cancer Immunotherapy

  2011cited by this paper
• Generation of robust CD8+ T‐cell responses against subdominant epitopes in conserved regions of HIV‐1 by repertoire mining with mimotopes

  2010cited by this paper
• Fine analysis of spontaneous MAGE-C1/CT7–specific immunity in melanoma patients

  2010cited by this paper
• Adoptive T cell therapy of cancer.

  2009cited by this paper
• HLA-A*0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D1

  2008cited by this paper
• Generation of mammaglobin-A-specific CD4 T cells and identification of candidate CD4 epitopes for breast cancer vaccine strategies

  2008cited by this paper
• Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers

  2008cited by this paper
• Identification of T-cell epitopes for cancer immunotherapy

  2007cited by this paper
• Availability of a Diversely Avid CD8+ T Cell Repertoire Specific for the Subdominant HLA-A2-Restricted HIV-1 Gag p2419–27 Epitope1

  2007cited by this paper
• Human T cell responses against melanoma.

  2006cited by this paper
• Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells

  2005cited by this paper
• High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens

  2005cited by this paper
• Immunization Using Autologous Dendritic Cells Pulsed with the Melanoma-Associated Antigen gp100-Derived G280-9V Peptide Elicits CD8+ Immunity

  2005cited by this paper
• Response of established human breast tumors to vaccination with mammaglobin-A cDNA.

  2004cited by this paper
• Mesothelin-specific CD8+ T Cell Responses Provide Evidence of In Vivo Cross-Priming by Antigen-Presenting Cells in Vaccinated Pancreatic Cancer Patients

  2004cited by this paper
• Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes

  2004cited by this paper
• Mammaglobin-based strategies for treatment of breast cancer.

  2004cited by this paper
• Generation of CD8+ Cytotoxic T Lymphocytes Against Breast Cancer Cells by Stimulation with Mammaglobin-A-Pulsed Dendritic Cells

  2003cited by this paper
• Mammaglobin-A is a tumor-associated antigen in human breast carcinoma.

  2003cited by this paper
• A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

  2002cited by this paper
• Identification of HLA‐A3‐restricted CD8+ T cell epitopes derived from mammaglobin‐A, a tumor‐associated antigen of human breast cancer

  2002cited by this paper
• High frequencies of circulating melanoma‐reactive CD8+ T cells in patients with advanced melanoma

  2000cited by this paper
• Mammaglobin, a Breast‐Specific Gene, and Its Utility as a Marker for Breast Cancer

  2000cited by this paper
• Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

  2000cited by this paper
• Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.

  2000cited by this paper
• Mammaglobin expression in primary, metastatic, and occult breast cancer.

  1999cited by this paper
• Isolation of differentially expressed sequence tags from human breast cancer.

  1994cited by this paper
• Identification of wild‐type and mutant p53 peptides binding to HLA‐A2 assessed by a peptide loading‐deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay

  1994cited by this paper
• Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

  1994cited by this paper
• Lymphocyte infiltrates as a prognostic variable in female breast cancer.

  1992cited by this paper
• Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2

  1987cited by this paper

• The therapeutic potential of immunotherapy in the treatment of breast cancer: Rational strategies and recent progress

  2023cites this paper
• Mammaglobin-A Expression Is Highly Specific for Tumors Derived from the Breast, the Female Genital Tract, and the Salivary Gland

  2023cites this paper
• Breast cancer vaccination: Latest advances with an analytical focus on clinical trials.

  2023cites this paper
• A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles

  2023cites this paper
• Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence

  2021cites this paper
• Recent advancements in the genetic engineering of microalgae

  2021cites this paper
• The concurrent effects of azurin and Mammaglobin-A genes in inhibition of breast cancer progression and immune system stimulation in cancerous BALB/c mice

  2019cites this paper
• Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

  2019cites this paper
• Immunologic approaches to cancer prevention-current status, challenges, and future perspectives.

  2016cites this paper